Brief: Biogen Canada Disappointed By Outcome Of Pan-Canadian Pharmaceutical Alliance Negotiations For Skyclarys
BRIEF-Biogen Canada Disappointed By Outcome Of Pan-Canadian Pharmaceutical Alliance Negotiations For Skyclarys June 16 (Reuters) - Biogen Inc BIIB.O:
BIOGEN CANADA: DISAPPOINTED BY OUTCOME OF PAN-CANADIAN PHARMACEUTICAL ALLIANCE NEGOTIATIONS FOR SKYCLARYS
BIOGEN CANADA: NEGOTIATIONS WITH PAN-CANADIAN PHARMACEUTICAL ALLIANCE FOR SKYCLARYS HAVE CONCLUDED WITHOUT REACHING AN AGREEMENT
Source text: ID:nCNWqy39Ca
Further company coverage: BIIB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biogen
See all newsHealth Rounds: Old cancer drug may help restore fertility for certain women
U.S. STOCKS ON THE MOVE-FactSet, Moderna, Goldman Sachs
U.S. STOCKS ON THE MOVE-Biogen, Incyte, Quantum Cyber
Biogen rises; co scales back drug programs acquired through $5.6 bln Apellis deal
Biogen scales back Apellis programs, trims research roles after $5.6 billion buyout